RECRUITING

Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Sensorum Health (Sensorum) is conducting a pilot study to determine if Sensorum's proprietary passive sensor network can be used to identify signals of early health decompensation in subjects prior to a hospitalization for chronic disease exacerbation or other ambulatory care sensitive conditions. Successful early detection would provide a window of opportunity to intervene outside of the acute setting in future interventional studies.

Official Title

Feasibility of Home-based, Ambient Passive Sensor Technology to Provide Early Warning of Health Decompensation by Detecting Deviations in Activities of Daily Living (ADLs) of Elderly Subjects With Diagnosed Chronic Heart Failure

Quick Facts

Study Start:2022-11-28
Study Completion:2024-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05865197

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Current Patient at Weill Cornell Medicine
  2. * Aged 55 years or older
  3. * Able to consent
  4. * Documented diagnosis of congestive heart failure (CHF)
  5. * At least 1 of the following prior hospital utilization events in the past 12 months
  6. * Inpatient admission for any reason
  7. * Facility observation stay for any reason
  8. * Emergency Department visit for any reason
  1. * Significant cardiac valvular disease
  2. * End-Stage Renal Disease (ESRD)
  3. * End-Stage CHF
  4. * End-Stage COPD

Contacts and Locations

Study Contact

Christine Fernandez
CONTACT
(973) 786-3573
christine@sensorum.ai
Andrew Hotchkiss
CONTACT
(973) 946-8382
andrew@sensorum.ai

Principal Investigator

Parag Goyal, M.D., MSc
PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University

Study Locations (Sites)

Weill Cornell Medicine
New York, New York, 10021
United States

Collaborators and Investigators

Sponsor: Sensorum Health Inc.

  • Parag Goyal, M.D., MSc, PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-28
Study Completion Date2024-09-01

Study Record Updates

Study Start Date2022-11-28
Study Completion Date2024-09-01

Terms related to this study

Additional Relevant MeSH Terms

  • CHF
  • Congestive Heart Failure